NCT02126826View on ClinicalTrials.gov

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Rising Oral Doses of BI 1026706 in Male and Female Healthy Subjects and Patients With Osteoarthritis of the Knee

PHASE1CompletedINTERVENTIONAL
Enrollment

58

Participants

Timeline

Start Date

May 28, 2014

Primary Completion Date

October 1, 2014

Study Completion Date

October 21, 2014

Conditions
Osteoarthritis
Interventions
DRUG

BI 1026706

Multiple Rising Doses (oral solution, tablet)

DRUG

Placebo to BI 1026706

Multiple Rising Doses (oral solution / tablet, identical to active treatment)

Trial Locations (1)

Unknown

1320.2.2 Boehringer Ingelheim Investigational Site, Berlin

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT02126826 - Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Rising Oral Doses of BI 1026706 in Male and Female Healthy Subjects and Patients With Osteoarthritis of the Knee | Biotech Hunter | Biotech Hunter